// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

22,622
Stories Indexed
Live
Feed Status
6
Data Sources
LATEST
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
ALL STORIES · 22,622 results Live
Leadership TDAY Sep 15 — 0.00

USA TODAY Announces Board Appointment

USA TODAY Co. appointed Babbel CEO Tim Allen to its Board of Directors, adding digital innovation expertise to its leadership team. The move is expected to bolster the company's st…

Leadership AETHL Sep 15 — 0.00

Executive Employment Agreement amended for change-in-control severance

Aethlon Medical Inc. amended James Frakes' employment agreement to ensure Change in Control severance benefits are paid in a single lump sum. This change removes the ability for th…

Leadership OTIS Sep 15 — 0.00

Otis CEO Judy Marks to retire in 2027

Otis Worldwide Chair, CEO and President Judith Marks will retire from the company and board upon the appointment of a successor, expected in 2027. She agreed to offer consulting s…

Earnings VRA Sep 15 — 0.00

Vera Bradley Reports FYQ27 Results, Revs Up 1.1%

Vera Bradley reported a 1.1% increase in consolidated net revenues to $71.6 million, with net income turning positive, as it continues its five-pillar transformation strategy.

M&A CTVA · VYLR Sep 15 ▲ +1.00

Corteva board approves Vylor distribution

The board approved the separation of Corteva's seed operating segment into a new publicly traded company, Vylor, with a dividend of one Vylor share for every one Corteva share, sch…

Buyback RBA · TSX: RBA Sep 15 — 0.00

RB Global to increase repurchase program to $1 billion

RB Global Inc. announced an increase to its share repurchase program from $500 million to $1 billion. The company recently repurchased over 5 million shares at an average price of …

Leadership LBRX Sep 15 — 0.00

LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer

LB Pharmaceuticals named neuropsychiatry expert Dr. Susan G. Kozauer as Chief Medical Officer, bolstering leadership ahead of key Phase 3 schizophrenia trial results.

Leadership NTRP Sep 15 ▲ +0.50

NextTrip announces premiere of JOURNY TV original series "I DO: In Destination" hosted by Ben Higgins

NextTrip’s JOURNY TV will premiere the first original series "I DO: In Destination" on October 4 and 5, 2026, advancing the company's content-to-commerce travel strategy.

Leadership SCRF Sep 15 — 0.00

Sadot Group names new CEO

Sadot Group Inc. announced Dr. Roy K. Zeigler appointed as new Chief Executive Officer effective immediately, succeeding the founder.

M&A PACKAGE Sep 15 — 0.00

Cheetah Net Buyback to Acquire JoyPak from Sellers

Cheetah Net Supply Chain Service Inc. entered into a definitive agreement to acquire JoyPak Supply LLC from Sellers Newland and Redwing for $788,000, increasing its ownership to 10…

Guidance ASPN Sep 15 — 0.00

Aspen Aerogels forges third quarter 2026 guidance

Aspen Aerogels Inc. released its September 2026 investor presentation outlining its financial outlook, excluding uncertainty from forward-looking statements.

M&A LIN Sep 15 ▲ +0.50

Lindblad Agrees to Buy Majority Interests in Three UK Companies

Lindblad Expeditions agreed to acquire a majority interest in White Desert, PNR Airways, and Echo Charlie. The deal includes consideration adjustments and is governed by a sale and…

Leadership QXL Sep 15 ▲ +1.48

Former Mossad Chief Joins Quantum X Labs as Strategic Advisor

Quantum X Labs appoints former Mossad Director Yossi Cohen to its Scientific Advisory Board to strengthen quantum computing and commercialization efforts, leveraging his background…

Regulatory ZEOX Sep 15 — 0.00

Zeo ScientifiX to Expand into Tennessee and Georgia

The company announced plans to expand into Georgia and Tennessee following the recent enactment of state laws establishing frameworks for certain stem cell therapies. The expansion…

Regulatory BLSM Sep 15 ▲ +0.80

BlossomHill Oncology Drug Targeted EGFR C797S Mutation

BlossomHill Therapeutics presented encouraging efficacy data from its Phase 1/2 SOLARA trial, demonstrating a 45% objective response rate from BH-30643 in EGFR C797S-positive NSCLC…

Offering AXON Sep 15 ▲ +0.20

Axon Announces 0% Convertible Senior Notes Offering

Axon intends to sell $1.0 billion of zero-coupon convertible notes due 2031, using proceeds for general corporate purposes, including growth and acquisitions. This debt issuance ra…

Buyback DRVN Sep 15 — 0.00

Driven Brands raises net leverage target, authorizes $100M buyback

Driven Brands Holdings established a long-term debt target of 2-3x and approved a $100M share repurchase program. The company previously achieved its 3x leverage target ahead of sc…

Offering FBLG Sep 15 — 0.00

FibroBiologics issues warrant to holder

FibroBiologics issued a warrant granting the holder the right to subscribe for shares until September 2026 after a Securities Purchase Agreement. This document details the terms, e…

Regulatory RCKT Sep 15 ▲ +0.20

Rocket aligns with FDA on Danon disease pivotal trial

The FDA confirmed the pivotal study design, protocols for continued dosing, and co-primary endpoints for RP-A501, including a 12-patient efficacy population.

Regulatory CNTB Sep 15 ▲ +0.70

Connect Biopharma reports positive early data for rademikibart in asthma study

Connect Biopharma announced positive preliminary data from a global Phase 2 study of its asthma drug rademikibart, showing a 66% reduction in treatment failures at 28 days and sign…